{"id":939,"date":"2022-12-05T16:27:35","date_gmt":"2022-12-05T15:27:35","guid":{"rendered":"http:\/\/apmonia-therapeutics.com\/?p=939"},"modified":"2022-12-05T16:42:53","modified_gmt":"2022-12-05T15:42:53","slug":"apmonia-therapeutics-announces-the-launch-of-the-thrombotax-program-with-the-support-of-the-anr-french-national-research-agency","status":"publish","type":"post","link":"https:\/\/apmonia-therapeutics.com\/index.php\/2022\/12\/05\/apmonia-therapeutics-announces-the-launch-of-the-thrombotax-program-with-the-support-of-the-anr-french-national-research-agency\/","title":{"rendered":"Apmonia Therapeutics announces the launch of the THROMBOTAX program with the support of the ANR (French National Research Agency)"},"content":{"rendered":"\n

<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":941,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12],"tags":[],"class_list":["post-939","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press-release"],"yoast_head":"\nApmonia Therapeutics announces the launch of the THROMBOTAX program with the support of the ANR (French National Research Agency) - Apmonia therapeutics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/apmonia-therapeutics.com\/index.php\/2022\/12\/05\/apmonia-therapeutics-announces-the-launch-of-the-thrombotax-program-with-the-support-of-the-anr-french-national-research-agency\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Apmonia Therapeutics announces the launch of the THROMBOTAX program with the support of the ANR (French National Research Agency) - Apmonia therapeutics\" \/>\n<meta property=\"og:url\" content=\"https:\/\/apmonia-therapeutics.com\/index.php\/2022\/12\/05\/apmonia-therapeutics-announces-the-launch-of-the-thrombotax-program-with-the-support-of-the-anr-french-national-research-agency\/\" \/>\n<meta property=\"og:site_name\" content=\"Apmonia therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-05T15:27:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-12-05T15:42:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/apmonia-therapeutics.com\/wp-content\/uploads\/2022\/12\/2022-12-05_16h26_23.png\" \/>\n\t<meta property=\"og:image:width\" content=\"763\" \/>\n\t<meta property=\"og:image:height\" content=\"1079\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin6547\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin6547\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/apmonia-therapeutics.com\\\/index.php\\\/2022\\\/12\\\/05\\\/apmonia-therapeutics-announces-the-launch-of-the-thrombotax-program-with-the-support-of-the-anr-french-national-research-agency\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/apmonia-therapeutics.com\\\/index.php\\\/2022\\\/12\\\/05\\\/apmonia-therapeutics-announces-the-launch-of-the-thrombotax-program-with-the-support-of-the-anr-french-national-research-agency\\\/\"},\"author\":{\"name\":\"admin6547\",\"@id\":\"https:\\\/\\\/apmonia-therapeutics.com\\\/#\\\/schema\\\/person\\\/6b64aaf82f3c886a35dba57ea5fbe3f5\"},\"headline\":\"Apmonia Therapeutics announces the launch of the THROMBOTAX program with the support of the ANR (French National Research Agency)\",\"datePublished\":\"2022-12-05T15:27:35+00:00\",\"dateModified\":\"2022-12-05T15:42:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/apmonia-therapeutics.com\\\/index.php\\\/2022\\\/12\\\/05\\\/apmonia-therapeutics-announces-the-launch-of-the-thrombotax-program-with-the-support-of-the-anr-french-national-research-agency\\\/\"},\"wordCount\":19,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/apmonia-therapeutics.com\\\/index.php\\\/2022\\\/12\\\/05\\\/apmonia-therapeutics-announces-the-launch-of-the-thrombotax-program-with-the-support-of-the-anr-french-national-research-agency\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/apmonia-therapeutics.com\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/2022-12-05_16h26_23.png\",\"articleSection\":[\"Press Release\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/apmonia-therapeutics.com\\\/index.php\\\/2022\\\/12\\\/05\\\/apmonia-therapeutics-announces-the-launch-of-the-thrombotax-program-with-the-support-of-the-anr-french-national-research-agency\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/apmonia-therapeutics.com\\\/index.php\\\/2022\\\/12\\\/05\\\/apmonia-therapeutics-announces-the-launch-of-the-thrombotax-program-with-the-support-of-the-anr-french-national-research-agency\\\/\",\"url\":\"https:\\\/\\\/apmonia-therapeutics.com\\\/index.php\\\/2022\\\/12\\\/05\\\/apmonia-therapeutics-announces-the-launch-of-the-thrombotax-program-with-the-support-of-the-anr-french-national-research-agency\\\/\",\"name\":\"Apmonia Therapeutics announces the launch of the THROMBOTAX program with the support of the ANR (French National Research Agency) - Apmonia therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/apmonia-therapeutics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/apmonia-therapeutics.com\\\/index.php\\\/2022\\\/12\\\/05\\\/apmonia-therapeutics-announces-the-launch-of-the-thrombotax-program-with-the-support-of-the-anr-french-national-research-agency\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/apmonia-therapeutics.com\\\/index.php\\\/2022\\\/12\\\/05\\\/apmonia-therapeutics-announces-the-launch-of-the-thrombotax-program-with-the-support-of-the-anr-french-national-research-agency\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/apmonia-therapeutics.com\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/2022-12-05_16h26_23.png\",\"datePublished\":\"2022-12-05T15:27:35+00:00\",\"dateModified\":\"2022-12-05T15:42:53+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/apmonia-therapeutics.com\\\/#\\\/schema\\\/person\\\/6b64aaf82f3c886a35dba57ea5fbe3f5\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/apmonia-therapeutics.com\\\/index.php\\\/2022\\\/12\\\/05\\\/apmonia-therapeutics-announces-the-launch-of-the-thrombotax-program-with-the-support-of-the-anr-french-national-research-agency\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/apmonia-therapeutics.com\\\/index.php\\\/2022\\\/12\\\/05\\\/apmonia-therapeutics-announces-the-launch-of-the-thrombotax-program-with-the-support-of-the-anr-french-national-research-agency\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/apmonia-therapeutics.com\\\/index.php\\\/2022\\\/12\\\/05\\\/apmonia-therapeutics-announces-the-launch-of-the-thrombotax-program-with-the-support-of-the-anr-french-national-research-agency\\\/#primaryimage\",\"url\":\"https:\\\/\\\/apmonia-therapeutics.com\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/2022-12-05_16h26_23.png\",\"contentUrl\":\"https:\\\/\\\/apmonia-therapeutics.com\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/2022-12-05_16h26_23.png\",\"width\":763,\"height\":1079},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/apmonia-therapeutics.com\\\/index.php\\\/2022\\\/12\\\/05\\\/apmonia-therapeutics-announces-the-launch-of-the-thrombotax-program-with-the-support-of-the-anr-french-national-research-agency\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/apmonia-therapeutics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Apmonia Therapeutics announces the launch of the THROMBOTAX program with the support of the ANR (French National Research Agency)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/apmonia-therapeutics.com\\\/#website\",\"url\":\"https:\\\/\\\/apmonia-therapeutics.com\\\/\",\"name\":\"Apmonia therapeutics\",\"description\":\"contact@apmonia-therapeutics.com\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/apmonia-therapeutics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/apmonia-therapeutics.com\\\/#\\\/schema\\\/person\\\/6b64aaf82f3c886a35dba57ea5fbe3f5\",\"name\":\"admin6547\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5383de875ee431c82c2031a4f3e2f1a19b7d0debe3754031e1ee8a4050246830?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5383de875ee431c82c2031a4f3e2f1a19b7d0debe3754031e1ee8a4050246830?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5383de875ee431c82c2031a4f3e2f1a19b7d0debe3754031e1ee8a4050246830?s=96&d=mm&r=g\",\"caption\":\"admin6547\"},\"url\":\"https:\\\/\\\/apmonia-therapeutics.com\\\/index.php\\\/author\\\/admin6547\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Apmonia Therapeutics announces the launch of the THROMBOTAX program with the support of the ANR (French National Research Agency) - Apmonia therapeutics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/apmonia-therapeutics.com\/index.php\/2022\/12\/05\/apmonia-therapeutics-announces-the-launch-of-the-thrombotax-program-with-the-support-of-the-anr-french-national-research-agency\/","og_locale":"en_US","og_type":"article","og_title":"Apmonia Therapeutics announces the launch of the THROMBOTAX program with the support of the ANR (French National Research Agency) - Apmonia therapeutics","og_url":"https:\/\/apmonia-therapeutics.com\/index.php\/2022\/12\/05\/apmonia-therapeutics-announces-the-launch-of-the-thrombotax-program-with-the-support-of-the-anr-french-national-research-agency\/","og_site_name":"Apmonia therapeutics","article_published_time":"2022-12-05T15:27:35+00:00","article_modified_time":"2022-12-05T15:42:53+00:00","og_image":[{"width":763,"height":1079,"url":"https:\/\/apmonia-therapeutics.com\/wp-content\/uploads\/2022\/12\/2022-12-05_16h26_23.png","type":"image\/png"}],"author":"admin6547","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin6547"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/apmonia-therapeutics.com\/index.php\/2022\/12\/05\/apmonia-therapeutics-announces-the-launch-of-the-thrombotax-program-with-the-support-of-the-anr-french-national-research-agency\/#article","isPartOf":{"@id":"https:\/\/apmonia-therapeutics.com\/index.php\/2022\/12\/05\/apmonia-therapeutics-announces-the-launch-of-the-thrombotax-program-with-the-support-of-the-anr-french-national-research-agency\/"},"author":{"name":"admin6547","@id":"https:\/\/apmonia-therapeutics.com\/#\/schema\/person\/6b64aaf82f3c886a35dba57ea5fbe3f5"},"headline":"Apmonia Therapeutics announces the launch of the THROMBOTAX program with the support of the ANR (French National Research Agency)","datePublished":"2022-12-05T15:27:35+00:00","dateModified":"2022-12-05T15:42:53+00:00","mainEntityOfPage":{"@id":"https:\/\/apmonia-therapeutics.com\/index.php\/2022\/12\/05\/apmonia-therapeutics-announces-the-launch-of-the-thrombotax-program-with-the-support-of-the-anr-french-national-research-agency\/"},"wordCount":19,"commentCount":0,"image":{"@id":"https:\/\/apmonia-therapeutics.com\/index.php\/2022\/12\/05\/apmonia-therapeutics-announces-the-launch-of-the-thrombotax-program-with-the-support-of-the-anr-french-national-research-agency\/#primaryimage"},"thumbnailUrl":"https:\/\/apmonia-therapeutics.com\/wp-content\/uploads\/2022\/12\/2022-12-05_16h26_23.png","articleSection":["Press Release"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/apmonia-therapeutics.com\/index.php\/2022\/12\/05\/apmonia-therapeutics-announces-the-launch-of-the-thrombotax-program-with-the-support-of-the-anr-french-national-research-agency\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/apmonia-therapeutics.com\/index.php\/2022\/12\/05\/apmonia-therapeutics-announces-the-launch-of-the-thrombotax-program-with-the-support-of-the-anr-french-national-research-agency\/","url":"https:\/\/apmonia-therapeutics.com\/index.php\/2022\/12\/05\/apmonia-therapeutics-announces-the-launch-of-the-thrombotax-program-with-the-support-of-the-anr-french-national-research-agency\/","name":"Apmonia Therapeutics announces the launch of the THROMBOTAX program with the support of the ANR (French National Research Agency) - Apmonia therapeutics","isPartOf":{"@id":"https:\/\/apmonia-therapeutics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/apmonia-therapeutics.com\/index.php\/2022\/12\/05\/apmonia-therapeutics-announces-the-launch-of-the-thrombotax-program-with-the-support-of-the-anr-french-national-research-agency\/#primaryimage"},"image":{"@id":"https:\/\/apmonia-therapeutics.com\/index.php\/2022\/12\/05\/apmonia-therapeutics-announces-the-launch-of-the-thrombotax-program-with-the-support-of-the-anr-french-national-research-agency\/#primaryimage"},"thumbnailUrl":"https:\/\/apmonia-therapeutics.com\/wp-content\/uploads\/2022\/12\/2022-12-05_16h26_23.png","datePublished":"2022-12-05T15:27:35+00:00","dateModified":"2022-12-05T15:42:53+00:00","author":{"@id":"https:\/\/apmonia-therapeutics.com\/#\/schema\/person\/6b64aaf82f3c886a35dba57ea5fbe3f5"},"breadcrumb":{"@id":"https:\/\/apmonia-therapeutics.com\/index.php\/2022\/12\/05\/apmonia-therapeutics-announces-the-launch-of-the-thrombotax-program-with-the-support-of-the-anr-french-national-research-agency\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/apmonia-therapeutics.com\/index.php\/2022\/12\/05\/apmonia-therapeutics-announces-the-launch-of-the-thrombotax-program-with-the-support-of-the-anr-french-national-research-agency\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/apmonia-therapeutics.com\/index.php\/2022\/12\/05\/apmonia-therapeutics-announces-the-launch-of-the-thrombotax-program-with-the-support-of-the-anr-french-national-research-agency\/#primaryimage","url":"https:\/\/apmonia-therapeutics.com\/wp-content\/uploads\/2022\/12\/2022-12-05_16h26_23.png","contentUrl":"https:\/\/apmonia-therapeutics.com\/wp-content\/uploads\/2022\/12\/2022-12-05_16h26_23.png","width":763,"height":1079},{"@type":"BreadcrumbList","@id":"https:\/\/apmonia-therapeutics.com\/index.php\/2022\/12\/05\/apmonia-therapeutics-announces-the-launch-of-the-thrombotax-program-with-the-support-of-the-anr-french-national-research-agency\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/apmonia-therapeutics.com\/"},{"@type":"ListItem","position":2,"name":"Apmonia Therapeutics announces the launch of the THROMBOTAX program with the support of the ANR (French National Research Agency)"}]},{"@type":"WebSite","@id":"https:\/\/apmonia-therapeutics.com\/#website","url":"https:\/\/apmonia-therapeutics.com\/","name":"Apmonia therapeutics","description":"contact@apmonia-therapeutics.com","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/apmonia-therapeutics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/apmonia-therapeutics.com\/#\/schema\/person\/6b64aaf82f3c886a35dba57ea5fbe3f5","name":"admin6547","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/5383de875ee431c82c2031a4f3e2f1a19b7d0debe3754031e1ee8a4050246830?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/5383de875ee431c82c2031a4f3e2f1a19b7d0debe3754031e1ee8a4050246830?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5383de875ee431c82c2031a4f3e2f1a19b7d0debe3754031e1ee8a4050246830?s=96&d=mm&r=g","caption":"admin6547"},"url":"https:\/\/apmonia-therapeutics.com\/index.php\/author\/admin6547\/"}]}},"_links":{"self":[{"href":"https:\/\/apmonia-therapeutics.com\/index.php\/wp-json\/wp\/v2\/posts\/939","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/apmonia-therapeutics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/apmonia-therapeutics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/apmonia-therapeutics.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/apmonia-therapeutics.com\/index.php\/wp-json\/wp\/v2\/comments?post=939"}],"version-history":[{"count":1,"href":"https:\/\/apmonia-therapeutics.com\/index.php\/wp-json\/wp\/v2\/posts\/939\/revisions"}],"predecessor-version":[{"id":943,"href":"https:\/\/apmonia-therapeutics.com\/index.php\/wp-json\/wp\/v2\/posts\/939\/revisions\/943"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/apmonia-therapeutics.com\/index.php\/wp-json\/wp\/v2\/media\/941"}],"wp:attachment":[{"href":"https:\/\/apmonia-therapeutics.com\/index.php\/wp-json\/wp\/v2\/media?parent=939"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/apmonia-therapeutics.com\/index.php\/wp-json\/wp\/v2\/categories?post=939"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/apmonia-therapeutics.com\/index.php\/wp-json\/wp\/v2\/tags?post=939"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}